Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 61,877 | 37,374 | 52,116 | 37,217 | 21,785 |
| Depreciation Amortization | 5,320 | 2,463 | 6,202 | 4,488 | 2,958 |
| Income taxes - deferred | 3,073 | -3,830 | 25,803 | 18,817 | 9,777 |
| Accounts receivable | -2,824 | 795 | -11,550 | -7,555 | -3,807 |
| Accounts payable and accrued liabilities | 299 | -4,391 | 7,565 | 3,542 | 1,906 |
| Other Working Capital | -11,913 | -9,102 | 5,333 | -5,246 | -6,727 |
| Other Operating Activity | 23,619 | 12,985 | 29,647 | 26,598 | 17,844 |
| Operating Cash Flow | $79,451 | $36,294 | $115,116 | $77,861 | $43,736 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,518 | -7,004 | -73,019 | -32,921 | -17,550 |
| PPE Investments | -17,675 | -9,804 | -50,415 | -24,039 | -10,453 |
| Purchase Of Investment | -6,400 | -400 | -2,899 | -149 | N/A |
| Investing Cash Flow | $-60,593 | $-17,208 | $-126,333 | $-57,109 | $-28,003 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -377 | -184 | -446 | -264 | -83 |
| Common Stock Issued | 6,320 | 3,555 | 12,380 | 9,034 | 6,533 |
| Other Financing Activity | -19,237 | -17,805 | -8,067 | -15,303 | -15,977 |
| Financing Cash Flow | $-13,294 | $-14,434 | $3,867 | $-6,533 | $-9,527 |
| Exchange Rate Effect | -68 | 278 | -1,841 | -1,381 | 272 |
| Beginning Cash Position | 39,040 | 39,040 | 48,231 | 48,231 | 48,231 |
| End Cash Position | 44,536 | 43,970 | 39,040 | 61,069 | 54,709 |
| Net Cash Flow | $5,496 | $4,930 | $-9,191 | $12,838 | $6,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | 79,451 | 36,294 | 115,116 | 77,861 | 43,736 |
| Capital Expenditure | -17,675 | -9,804 | -50,415 | -24,039 | -10,453 |
| Free Cash Flow | 61,776 | 26,490 | 64,701 | 53,822 | 33,283 |